Ethical resource allocation in pandemics

Tags 

In a pandemic setting, excess demand on ordinary healthcare resources and services

is expected. Access to ventilators, vaccines, antivirals, and other necessary resources

in hospitals and in the community will need to be prioritized. Clinical criteria is

insufficient in priority setting. Value - based decisions in a pandemic setting need to be

made.

The ethical goals of resource allocation or priority setting are legitimacy, fairness, and

equity. Research indicates the following parameters are acceptable to the public in

resource allocation decisions: need, survivability, and social value. Need takes into

consideration not just the sickest person; persons who are responsible for caring for

others may take priority. Social utility of individuals (healthcare workers, critical

infrastructure workers, etc.) who are sick is a key concept in prioritizing. Establishing

transparent priority setting criteria in advance of a crisis is another key concept, to

enforce fairness and public trust in priority setting. There is public consensus that

priority should be given to healthcare workers, whose social utility value is high; and

whose risk assumption is high. Research indicates there is public consensus that

children should be given second priority after healthcare workers. The WHO (2008)

emphasizes that priority setting is typically based on the principle of efficiency (saving

most lives), which prioritizes protecting individuals responsible for caring the sick, and

is not necessarily based on prioritizing resources for the “sickest”. The principle of

equity is typically a failed principle in priority setting because equitable distribution of

resources may not achieve the goals of public safety in pandemic situations.

In the WHO report “Ethical Considerations in Developing a Public Health Response to

Pandemic Influenza”, the elements of a fair process for setting priorities are described

(http://www.who.int/csr/resources/publications/WHO_CDS_EPR_GIP_2007_2c.pdf):

- Publicity: The process, including the rationale for setting priorities, must be made

public and transparent; consultations and public hearings should be held. Publicity and

involvement of key stakeholders are particularly important in con¬texts where policy

and programmatic decisions occur in a multi-actor environment and affect large parts

of the population.

- Relevance: The affected stakeholders must view as relevant the reasons, principles

and evidence that form the basis of the rationale for fair decision-making on priorities.

- Reversibility and appeals mechanisms: In the case of new evidence and arguments,

the process must allow for reconsidering and revising decisions. It must allow for an

appeals process that protects those who have legitimate reasons for being an

exception to the adopted ropolicies.

-Enforcement or regulation: There must be a mechanism in place that ensures that the

previous three conditions are met.

Source: http://ukhealthcare.uky.edu/uploadedfiles/UKpandemicethicsresource.pdf

 

MMLAP and other EU Projects

Health system analysis to support capacity development in response to the threat of pandemic influenza in Asia
Making society an active participant in water adaptation to global change
Public Participation in Developing a Common Framework for Assessment and Management of Sustainable Innovation
Engaging all of Europe in shaping a desirable and sustainable future
Expect the unexpected and know how to respond
Driving innovation in crisis management for European resilience
Effective communication in outbreak management: development of an evidence-based tool for Europe
Solutions to improve CBRNe resilience
Network for Communicable Disease Control in Southern Europe and Mediterranean Countries
Developing the framework for an epidemic forecast infrastructure
Strengthening of the national surveillance system for communicable diseases
Surveillance of vaccine preventable hepatitis
European monitoring of excess mortality for public health action
European network for highly infectious disease
Dedicated surveillance network for surveillance and control of vaccine preventable diseases in the EU
Modelling the spread of pandemic influenza and strategies for its containment and mitigation
Cost-effectiveness assessment of european influenza human pandemic alert and response strategies
Bridging the gap between science, stakeholders and policy makers
Promotion of immunization for health professionals in Europe
Towards inclusive research programming for sustainable food innovations
Addressing chronic diseases and healthy ageing across the life cycle
Medical ecosystem – personalized event-based surveillance
Studying the many and varied economic, social, legal and ethical aspects of the recent developments on the Internet, and their consequences for the individual and society at large
Get involved in the responsible marine research and innovation
Knowledge-based policy-making on issues involving science, technology and innovation, mainly based upon the practices in Parliamentary Technology Assessment
Assessment of the current pandemic preparedness and response tools, systems and practice at national, EU and global level in priority areas
Analysis of innovative public engagement tools and instruments for dynamic governance in the field of Science in Society
Public Engagement with Research And Research Engagement with Society
Computing Veracity – the Fourth Challenge of Big Data
Providing infrastructure, co-ordination and integration of existing clinical research networks on epidemics and pandemics
Promote vaccinations among migrant population in Europe
Creating mechanisms for effectively tackling the scientific and technology related challenges faced by society
Improve the quality of indoor air, keeping it free from radon
Improving respect of ethics principles and laws in research and innovation, in line with the evolution of technologies and societal concerns
Investigating how cities in the West securitise against global pandemics
Creating a structured dialogue and mutual learning with citizens and urban actors by setting up National Networks in 10 countries across Europe
Identifying how children can be change agents in the Science and Society relationship
Establishing an open dialogue between stakeholders concerning synthetic biology’s potential benefits and risks
Transparent communication in Epidemics: Learning Lessons from experience, delivering effective Messages, providing Evidence